Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2021-06-18

Clinical Trial Update: Misoprostol in Office Hysteroscopy and Endometrial Biopsy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating misoprostol in office hysteroscopy and endometrial biopsy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MISOPROSTOL (Misoprostol)

Snippet

Sponsor: University of South Florida | Conditions: Office Hysteroscopy and Endometrial Biopsy | Phase 4 | Status: WITHDRAWN